{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:58:33Z","timestamp":1788872313762,"version":"build-2803163510"},"reference-count":37,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,6]],"date-time":"2022-11-06T00:00:00Z","timestamp":1667692800000},"content-version":"vor","delay-in-days":3172,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"The Research Fund of the Capital Region of Denmark"},{"DOI":"10.13039\/100007405","name":"The Danish Heart Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007405","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1111\/jth.12484","type":"journal-article","created":{"date-parts":[[2013,12,11]],"date-time":"2013-12-11T07:16:39Z","timestamp":1386746199000},"page":"297-305","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"title":["Endogenous sex hormones and risk of venous thromboembolism in women and men"],"prefix":"10.1016","volume":"12","author":[{"given":"H.N.","family":"Holmegard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.G.","family":"Nordestgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Schnohr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Tybj\u00e6rg\u2010Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Benn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/jth.12484_bb0010","first-page":"e18","article-title":"Heart disease and stroke statistics \u2013 2011 update: a report from the American Heart Association","volume":"123","author":"Roger","year":"2011","journal-title":"Circulation"},{"key":"10.1111\/jth.12484_bb0015","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.ejim.2007.03.016","article-title":"Pulmonary embolism associated with the use of anabolic steroids","volume":"19","author":"Liljeqvist","year":"2008","journal-title":"Eur J Intern Med"},{"key":"10.1111\/jth.12484_bb0020","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1111\/j.1538-7836.2005.01415.x","article-title":"Venous thromboembolism: disease burden, outcomes and risk factors","volume":"3","author":"Heit","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.12484_bb0025","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial","volume":"288","author":"Rossouw","year":"2002","journal-title":"JAMA"},{"key":"10.1111\/jth.12484_bb0030","doi-asserted-by":"crossref","first-page":"689","DOI":"10.7326\/0003-4819-132-9-200005020-00002","article-title":"Postmenopausal hormone therapy increases risk for venous thromboembolic disease. The Heart and Estrogen\/progestin Replacement Study","volume":"132","author":"Grady","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1111\/jth.12484_bb0035","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1001\/jama.288.1.58","article-title":"Noncardiovascular disease outcomes during 6.8\u00a0years of hormone therapy: Heart and Estrogen\/progestin Replacement Study follow\u2010up (HERS II)","volume":"288","author":"Hulley","year":"2002","journal-title":"JAMA"},{"key":"10.1111\/jth.12484_bb0040","doi-asserted-by":"crossref","first-page":"b2890","DOI":"10.1136\/bmj.b2890","article-title":"Hormonal contraception and risk of venous thromboembolism: national follow\u2010up study","volume":"339","author":"Lidegaard","year":"2009","journal-title":"BMJ"},{"key":"10.1111\/jth.12484_bb0045","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/S0140-6736(80)91550-0","article-title":"Oral contraceptives and thromboembolic disease: effects of lowering oestrogen content","volume":"1","author":"B\u00f6ttiger","year":"1980","journal-title":"Lancet"},{"key":"10.1111\/jth.12484_bb0050","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1001\/jama.1973.03230060030009","article-title":"The Coronary Drug Project. Findings leading to discontinuation of the 2.5\u2010mg day estrogen group. The coronary Drug Project Research Group","volume":"226","year":"1973","journal-title":"JAMA"},{"key":"10.1111\/jth.12484_bb0055","first-page":"751","article-title":"Treatment of prostatic cancer: studies by the Veterans Administration cooperative urological research group","volume":"48","author":"Byar","year":"1972","journal-title":"Bull N Y Acad Med"},{"key":"10.1111\/jth.12484_bb0060","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0306-9877(91)90079-E","article-title":"Anabolic\/androgenic steroid abuse and thrombosis: is there a connection?","volume":"35","author":"Ferenchick","year":"1991","journal-title":"Med Hypotheses"},{"key":"10.1111\/jth.12484_bb0065","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.maturitas.2008.11.001","article-title":"Study of adverse outcomes in women using testosterone therapy","volume":"62","author":"van Staa","year":"2009","journal-title":"Maturitas"},{"key":"10.1111\/jth.12484_bb0070","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1001\/archinte.158.6.585","article-title":"Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25\u2010year population\u2010based study","volume":"158","author":"Silverstein","year":"1998","journal-title":"Arch Intern Med"},{"key":"10.1111\/jth.12484_bb0075","doi-asserted-by":"crossref","first-page":"I4","DOI":"10.1161\/01.CIR.0000078468.11849.66","article-title":"The epidemiology of venous thromboembolism","volume":"107","author":"White","year":"2003","journal-title":"Circulation"},{"key":"10.1111\/jth.12484_bb0080","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1530\/EJE-08-0888","article-title":"Endogenous sex hormone levels in men are not associated with risk of venous thromboembolism: the Tromso study","volume":"160","author":"Svartberg","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"10.1111\/jth.12484_bb0085","first-page":"1","article-title":"The Copenhagen City Heart Study. Osterbrounders\u00f8gelsen. A book of tables with data from the first examination (1976\u201378) and a five year follow\u2010up (1981\u201383). The Copenhagen City Heart Study Group","volume":"41","author":"Appleyard","year":"1989","journal-title":"Scand J Soc Med Suppl"},{"key":"10.1111\/jth.12484_bb0090","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1001\/jama.298.3.299","article-title":"Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women","volume":"298","author":"Nordestgaard","year":"2007","journal-title":"JAMA"},{"key":"10.1111\/jth.12484_bb0095","series-title":"Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycemia","year":"2006"},{"key":"10.1111\/jth.12484_bb0100","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1161\/CIRCULATIONAHA.107.715698","article-title":"Extreme lipoprotein(a) levels and risk of myocardial infarction in the general population: the Copenhagen City Heart Study","volume":"117","author":"Kamstrup","year":"2008","journal-title":"Circulation"},{"key":"10.1111\/jth.12484_bb0105","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1200\/JCO.2008.18.8367","article-title":"Elevated plasma YKL\u201040 predicts increased risk of gastrointestinal cancer and decreased survival after any cancer diagnosis in the general population","volume":"27","author":"Johansen","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1111\/jth.12484_bb0110","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/oxfordjournals.aje.a010013","article-title":"Underestimation of risk associations due to regression dilution in long\u2010term follow\u2010up of prospective studies","volume":"150","author":"Clarke","year":"1999","journal-title":"Am J Epidemiol"},{"key":"10.1111\/jth.12484_bb0115","first-page":"727","article-title":"Royal College of General Practitioners' Oral Contraception Study. Mortality among oral\u2010contraceptive users","volume":"2","author":"Beral","year":"1977","journal-title":"Lancet"},{"key":"10.1111\/jth.12484_bb0120","first-page":"541","article-title":"Royal College of General Practitioners' Oral Contraception Study. Further analyses of mortality in oral contraceptive users","volume":"1","author":"Layde","year":"1981","journal-title":"Lancet"},{"key":"10.1111\/jth.12484_bb0125","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/S0140-6736(61)91061-3","article-title":"Letters to the editor: pulmonary embolism","volume":"278","author":"Jordan","year":"1961","journal-title":"The Lancet"},{"key":"10.1111\/jth.12484_bb0130","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1136\/bmj.2.5548.355","article-title":"Risk of thromboembolic disease in women taking oral contraceptives. A preliminary communication to the Medical Research Council by a Subcommittee","volume":"2","year":"1967","journal-title":"Br Med J"},{"key":"10.1111\/jth.12484_bb0135","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1001\/archinte.164.18.1965","article-title":"Risk of venous thromboembolic disease associated with hormonal contraceptives and hormone replacement therapy: a clinical review","volume":"164","author":"Gomes","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1111\/jth.12484_bb0140","doi-asserted-by":"crossref","first-page":"441","DOI":"10.2164\/jandrol.110.011536","article-title":"Further evidence of the clinical, hormonal, and genetic heterogeneity of Klinefelter syndrome: a study of 216 infertile Egyptian patients","volume":"33","author":"Abdel\u2010Razic","year":"2012","journal-title":"J Androl"},{"key":"10.1111\/jth.12484_bb0145","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1210\/jcem-57-3-645","article-title":"Sex hormone\u2010binding globulin changes with androgen replacement","volume":"57","author":"Plymate","year":"1983","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/jth.12484_bb0150","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1210\/jc.2003-032006","article-title":"Long\u2010term testosterone gel (AndroGel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal men","volume":"89","author":"Wang","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/jth.12484_bb0155","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.contraception.2010.03.020","article-title":"Clinical trials in male hormonal contraception","volume":"82","author":"Nieschlag","year":"2010","journal-title":"Contraception"},{"key":"10.1111\/jth.12484_bb0160","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1046\/j.1365-2265.1997.2601068.x","article-title":"Mortality and morbidity in transsexual subjects treated with cross\u2010sex hormones","volume":"47","author":"van Kesteren","year":"1997","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1111\/jth.12484_bb0165","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1139\/O07-011","article-title":"Physiological testosterone stimulates tissue plasminogen activator and tissue factor pathway inhibitor and inhibits plasminogen activator inhibitor type 1 release in endothelial cells","volume":"85","author":"Jin","year":"2007","journal-title":"Biochem Cell Biol"},{"key":"10.1111\/jth.12484_bb0170","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.thromres.2007.03.008","article-title":"Experimental arterial thrombosis regulated by androgen and its receptor via modulation of platelet activation","volume":"121","author":"Li","year":"2007","journal-title":"Thromb Res"},{"key":"10.1111\/jth.12484_bb0175","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1111\/j.1538-7836.2010.03930.x","article-title":"17\u03b1\u2010Ethinylestradiol rapidly alters transcript levels of murine coagulation genes via estrogen receptor \u03b1","volume":"8","author":"Cleuren","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.12484_bb0180","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1182\/blood-2012-01-405498","article-title":"Chronic estradiol treatment reduces platelet responses and protects mice from thromboembolism through the hematopoietic estrogen receptor \u03b1","volume":"120","author":"Val\u00e9ra","year":"2012","journal-title":"Blood"},{"key":"10.1111\/jth.12484_bb0185","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.thromres.2003.11.014","article-title":"Estrogen administration enhances thrombin generation in rats","volume":"112","author":"Ohashi","year":"2003","journal-title":"Thromb Res"},{"key":"10.1111\/jth.12484_bb0190","series-title":"Goodman & Gilman's The Pharmacologic Basis of Therapeutics","first-page":"1541","article-title":"Estrogens and progestins","author":"Loose","year":"2006"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjth.12484","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjth.12484","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622038715?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622038715?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/jth.12484\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:06:48Z","timestamp":1761534408000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622038715"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S1538783622038715"],"URL":"https:\/\/doi.org\/10.1111\/jth.12484","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Endogenous sex hormones and risk of venous thromboembolism in women and men","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/jth.12484","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}